MyAverix Finance MyAverix Finance

BE · General

PTC Therapeutics Inc. (BH3)

Diversified

PTC Therapeutics Inc. (BH3) is listed on BE in the General sector. Industry: Diversified. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for BH3

P/E ratio
18.00

PTC Therapeutics Inc. (BH3) — FAQ

What is BH3's P/E ratio?

The price-to-earnings (P/E) ratio for PTC Therapeutics Inc. (BH3) is 18.00 (data as of 2026-03-22).

Does PTC Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for PTC Therapeutics Inc. (BH3). Check the MyAverix Finance app for the latest dividend data.

What sector is PTC Therapeutics Inc. in?

PTC Therapeutics Inc. (BH3) is classified in the General sector (Diversified industry).

What exchange is BH3 listed on?

BH3 is listed on BE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play